Background Frailty results from declining reserve and function and is a modifiable cardiovascular risk-factor. Despite this, there is limited evidence surrounding its role in lower-risk TAVR cohorts. Objectives This study aimed to evaluate frailty among contemporary TAVR patients, delineate the impact of biochemical an...
A. Butala, J. Hogarty, S. Nanayakkara et al.· JACC: Advances· 0 citations
Transcatheter aortic valve implantation (TAVI) has evolved from a last resort for inoperable aortic stenosis into the preferred bioprosthetic strategy across much of the surgical‐risk spectrum for anatomically suitable patients. As it expands into younger and lower‐risk populations, the central question is no longer wh...
M. Lankaputhra, N. Htun, D. Stub· Internal medicine journal (P...· 0 citations
The HFpEF-ABA score identifies a high-risk phenotype of AS patients undergoing TAVI, characterised by adverse cardiac remodelling, poorer functional status, and increased post-TAVI complications.
Jennifer Y. Zhou, S. Nanayakkara, R. Johnston et al.· Heart, Lung and Circulation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.